These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9881 related articles for article (PubMed ID: 1697512)

  • 1. Effect of ultraviolet irradiation on the antitumor activity of bleomycin.
    Mori H
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1400-2. PubMed ID: 1697512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enhancement of antitumor activity of bleomycin A5 in mouse sarcoma 180 cells in vitro and in vivo by verapamil].
    He NG; Zhang HQ; Wang RH; Yang XL; Xue SB
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):381-4. PubMed ID: 1716815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of photo-activated bleomycin on deoxyribonuclease I, exonuclease III and deoxyribonucleic acid polymerase I reactions.
    Mori H
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):680-3. PubMed ID: 2473848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of bleomycin A5 with calmodulin inhibitor on the proliferation of S-180 cells in vitro].
    Zhang HQ; He NG; Xue SB
    Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):470-3. PubMed ID: 1718143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis by bleomycin and its copper complex.
    Oikawa T; Hirotani K; Ogasawara H; Katayama T; Ashino-Fuse H; Shimamura M; Iwaguchi T; Nakamura O
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1790-2. PubMed ID: 1698565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro selection and characterization of a bleomycin-resistant subline of B16 melanoma.
    Zuckerman JE; Raffin TA; Brown JM; Newman RA; Etiz BB; Sikic BI
    Cancer Res; 1986 Apr; 46(4 Pt 1):1748-53. PubMed ID: 2418953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiation reduces bleomycin sensitivity in cervical squamous cancer cells in vitro.
    Tanaka T; Yukawa K; Umesaki N
    Eur J Gynaecol Oncol; 2007; 28(4):273-7. PubMed ID: 17713091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor effect of targeted nanoliposomal bleomycin.
    Chiani M; Azadmanesh K; Shokrgozar MA; Mehrabi MR; Akbarzadeh A; Norouzian D
    Chem Biol Drug Des; 2017 Nov; 90(5):953-961. PubMed ID: 28498511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity.
    Burgy O; Wettstein G; Bellaye PS; Decologne N; Racoeur C; Goirand F; Beltramo G; Hernandez JF; Kenani A; Camus P; Bettaieb A; Garrido C; Bonniaud P
    Sci Transl Med; 2016 Feb; 8(326):326ra20. PubMed ID: 26888428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and antitumor properties of bleomycin and several of its metal complexes.
    Rao EA; Saryan LA; Antholine WE; Petering DH
    J Med Chem; 1980 Dec; 23(12):1310-8. PubMed ID: 6161253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms Enhancing the Cytotoxic Effects of Bleomycin plus Suicide or Interferon-β Gene Lipofection in Metastatic Human Melanoma Cells.
    Fondello C; Agnetti L; Glikin GC; Finocchiaro LME
    Anticancer Agents Med Chem; 2018; 18(9):1338-1348. PubMed ID: 29866016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth.
    Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R
    Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combined treatment with 40 degrees C hyperthermia and bleomycin on the accumulation of heat shock protein in murine L cells.
    Jin ZH; Shioura H; Kano E; Hayashi S; Hatashita M; Matsumoto H; Ohtsubo T
    Int J Oncol; 2002 Jan; 20(1):137-42. PubMed ID: 11743654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization, and in vitro evaluation of bleomycin-containing nanoliposomes.
    Chiani M; Shokrgozar MA; Azadmanesh K; Norouzian D; Mehrabi MR; Najmafshar A; Akbarzadeh A
    Chem Biol Drug Des; 2017 Apr; 89(4):492-497. PubMed ID: 27637429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo sensitization of human lung carcinoma to bleomycin by the cysteine proteinase inhibitor E-64.
    Jani JP; Mistry JS; Morris G; Lazo JS; Sebti SM
    Oncol Res; 1992; 4(2):59-63. PubMed ID: 1375852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of three bleomycin-resistant human carcinoma cell lines and their cross-resistance to other antitumor agents.
    Urade M; Sugi M; Miyazaki T
    Cancer; 1988 Apr; 61(8):1501-7. PubMed ID: 2450630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
    Sebti SM; Jani JP; Mistry JS; Gorelik E; Lazo JS
    Cancer Res; 1991 Jan; 51(1):227-32. PubMed ID: 1703034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of thioredoxin in bleomycin-injured airway epithelium: possible role of protection against bleomycin induced epithelial injury.
    Gon Y; Sasada T; Matsui M; Hashimoto S; Takagi Y; Iwata S; Wada H; Horie T; Yodoi J
    Life Sci; 2001 Mar; 68(16):1877-88. PubMed ID: 11292065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain improvement by combined UV mutagenesis and ribosome engineering and subsequent fermentation optimization for enhanced 6'-deoxy-bleomycin Z production.
    Zhu X; Kong J; Yang H; Huang R; Huang Y; Yang D; Shen B; Duan Y
    Appl Microbiol Biotechnol; 2018 Feb; 102(4):1651-1661. PubMed ID: 29279956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
    Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
    Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 495.